Froogh Shams
1,2, Alka Hasani
1,2*, Mohammad Ahangarzadeh Rezaee
2, Mohammad Reza Nahaie
2, Akbar Hasani
3, Mohammad Hossein Soroush Bar Haghi
2, Ali Pormohammad
1,2, Asghar Elli Arbatan
41 Research Center of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Department of Medical Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Drug Applied Research Center and Department of Clinical Biochemistry and Laboratory Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
4 Central Laboratory, Sina Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Purpose: The study aimed at
assessing any association between quinolone resistance, MDR and ESBL production
and their relation with the presence of integrons in Esherichia coli and
Klebsiella pneumoniae.
Methods: E.coli
and K.pneumoniae isolated from various clinical infections were fully
identified and analyzed for being quinolone resistant. These isolates were
further tested for ESBL production, multi drug resistance and carriage of
integrons.
Results: In total, 135
isolates were confirmed as quinolone resistant. K.pneumoniae was
observed as potent ESBL producer in comparison to E.coli. Ciprofloxacin
resistance in both organisms was related significantly with the presence of
integron class 1, co-presence of class 1 and 2 as well as to the presence of ESBL
production (p< 0.001). However, nalidixic acid resistance was related
significantly (p< 0.01) with only integron class 1 and to the presence of
ESBL production. Class 1 and 2 integrons were found in 73.5% of MDR isolates
with 13.2% of them possessing both intI1 and intI2 genes.
Conclusion: Prevalence of
quinolone resistance together with ESBL production and MDR in E.coli and
K.pneumoniae has contributed to the emergence of antibacterial
resistance burden. The higher integron prevalence in our isolates advocates the
potentiality of these isolates as a source for dissemination of resistance
determinants.